Transaction · 0001415889-25-000833

Feeley Kevin

Feeley Kevin, CFO, reported an open-market or private sale at GeneDx Holdings Corp. involving 337.000000 shares for an estimated $25963.39. Reported holdings after the transaction were 26770.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCFO
WGSGeneDx Holdings Corp.
Filing timeJan 06
Trade dateJan 02, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

WGS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
WGS since 2025-01-06Filed 606 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001415889-25-000833
Class A Common Stock
Transaction date
Jan 02, 2025
Filed Jan 06, 2025, 11:04 PM · 4d delay
Shares
337 sh
$7.70k per share
Estimated value
-$2.59M
Computed from shares × price
Holdings after
26.7k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CHIEF FINANCIAL OFFICER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2024.

  2. F2

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.66 to $75.50 per share, inclusive. The Reporting Person undertake…

  3. F3

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.73 to $76.64 per share, inclusive. The Reporting Person undertake…

  4. F4

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.75 to $77.67 per share, inclusive. The Reporting Person undertake…

Original filing · 0001415889-25-000833
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

WGS